ASSOCIATION OF CEREBROVASCULAR ACCIDENT WITH POLYCYTHEMIA VERA
Journal Title: Journal of Ayub Medical College Abbottabad - Year 2019, Vol 31, Issue 3
Abstract
Polycythemia Vera is a rare myeloproliferative neoplasm usually having ischemic stroke/thrombotic episode as presenting complaint. The patient reported had history of Cerebrovascular accident (CVA) two years back but blood cell counts were normal that time with no Polycythaemia Vera.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP673663
- DOI -
- Views 193
- Downloads 0
GASTRIC DUPLICATION CYST: A RARE CONGENITAL ANOMALY CAUSING GASTRIC OUTLET OBSTRUCTION
Gastrointestinal duplication cyst is a rare congenital anomaly with a reported incidence of 1 in 4500 live births. Any part of gastrointestinal tract from mouth to anus can be affected with this anomaly. Among gastrointe...
COMPARISON OF MICROVASCULAR FREE TISSUE TRANSFER IN ADULT AND PAEDIATRIC PATIENTS
Background: Free tissue transfer is a routine practice in adults with good success rates. Further advances in techniques and microsurgical skills have proved that free tissue transfer in paediatric population is feasible...
OBESITY AND DIABETES AS DETERMINANTS OF VITAMIN D DEFICIENCY
Background: Vitamin D has been the focus of attention in the recent past owing to its multitude of effects on various organ systems including immune system, endocrine, cardiovascular etc. Diabetes mellitus and obesity ar...
FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH ACUTE KIDNEY INJURY UNDERGOING CORONARY ARTERY BYPASS GRAFTING
Background: Diabetes mellitus has a major role in developing acute kidney injury (AKI) in patients undergoing coronary artery bypass grafting (CABG). The study was conducted with the aim to determine the frequency of dia...
EFFICACY OF INTERRUPTED AND MODIFIED DEFERASIROX DOSE AMONG PAEDIATRIC PATIENTS WITH Β- THALASSEMIA MAJOR AND HIGH ALANINE AMINOTRANSFERASE LEVEL
Background: Abnormal liver function tests lead to interruptions of Deferasirox therapy. The aim of this study is to assess the efficacy of deferasirox dose 30 mg /kg /day in maintaining cardiac protective level of serum...